ACE2, a homologue of ACE, has been shown to exert anti‐fibrosis and anti‐hypertrophy effects and to reduce LV remodelling in patients with type 1 diabetes 6, 7. The gene discussed is ACE2; the disease is type 1 diabetes mellitus.